Endocrine Abstracts

Aim: GH is used to treat short stature in children with GH deficiency (GHD), Turner syndrome (TS) and born small for gestational age (SGA). As GH is injected daily, treatment adherence may be problematic. To maximise adherence, improvements in injection devices have been targeted. This report compares intuitiveness and ease of use of two disposable GH devices: Norditropin NordiFlex (NF; Novo Nordisk A/S, Bagsværd, Denmark) and GoQuick (GQ, Pfizer, Inc., New York, USA).</p...